Alpana Singh

Pathobiology-guided diagnostic advances, biomarker discovery, and emerging therapeutic strategies in progressive multiple sclerosis.

Current advances in the therapeutic landscape of progressive MS are summarized, highlighting recently approved treatments as well as promising agents under clinical investigation, with particular emphasis on the underlying mechanisms of action of these therapies and their potential to modify disease progression, restore neural function, and support the development of personalized treatment strategies for patients with PMS.